J Michael Grelier Clinical is categorized under Research and Development Laboratories in Tuscaloosa, AL .
J Michael Grelier Clinical was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Kris Coss, Office Manager at the company’s single location by writing to 100 Towncenter Boulevard, Tuscaloosa, Alabama AL 35406 or by phoning (205) 464-4711. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | J Michael Grelier Clinical |
| Contact Person: | Kris Coss, Office Manager |
| Address: | 100 Towncenter Boulevard, Tuscaloosa, Alabama 35406 |
| Phone Number: | (205) 464-4711 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 5417110 |
| Share This Business: |
J Michael Grelier Clinical was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Kris Coss, Office Manager for inquiries that concern J Michael Grelier Clinical by calling the company number (205) 464-4711, as your correspondence is most welcome. Additionally, the physical location of the single location of J Michael Grelier Clinical can be found at the coordinates 33.232186,-87.536832 as well as the street address 100 Towncenter Boulevard in Tuscaloosa, Alabama 35406.
For its online presence, you may visit J Michael Grelier Clinical’s website at and engage with its social media outlets through on Twitter and on Facebook.